国: イギリス
言語: 英語
ソース: MHRA (Medicines & Healthcare Products Regulatory Agency)
Hydrocortisone butyrate
Neon Healthcare Ltd
D07AB02
Hydrocortisone butyrate
1mg/1gram
Cutaneous cream
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13040000; GTIN: 5013346026783 5013346026790
IAT001 (LFT293) Page 1+2, 145x270 mm 145 mm 270 mm PACKAGE LEAFL ET: INFORMATION FOR THE USER LOCOID LIPOCREAM ® Hydrocortisone butyrate 0.1% w/w 053058 READ ALL OF THIS LEAFL ET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leafl et. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side eff ects, talk to your doctor, pharmacist or nurse. This includes any possible side eff ects not listed in this leafl et. See section 4. WHAT IS IN THIS LEAFL ET: 1. What Locoid Lipocream is and what it is used for 2. What you need to know before you use Locoid Lipocream 3. How to use Locoid Lipocream 4. Possible side eff ects 5. How to store Locoid Lipocream 6. Contents of the pack and other information 1. WHAT LOCOID LIPOCREAM IS AND WHAT IT IS USED FOR Locoid Lipocream contains the active substance hydrocortisone butyrate. This is a corticosteroid which when made up as a cream is for use on the skin. This is known as topical application. Topical corticosteroids are ranked as mildly potent, moderately potent, potent and very potent; Locoid Lipocream is classed as potent. Topical corticosteroids are able to reduce the infl ammation caused by a variety of skin conditions, and so allow it to get better. They can also aff ect the cause of the condition, which can lead to its healing. Locoid Lipocream is indicated in adults, children and infants. It is used to treat a variety of skin conditions that respond to topical corticosteroids. Among these are eczema and dermatitis (itching) of all types including atopic (childhood) eczema, photodermatitis (itching caused by exposure to light) and dermatitis caused by skin irritants and allergies. It can also be used in the treatment of psoriasis, a condition resulting in thickening of areas of the sk 完全なドキュメントを読む
OBJECT 1 LOCOID LIPOCREAM Summary of Product Characteristics Updated 15-Sep-2016 | Leo Laboratories Limited 1. Name of the medicinal product Locoid Lipocream 2. Qualitative and quantitative composition Locoid Lipocream contains 0.1% w/w hydrocortisone butyrate. Excipient(s) with known effect: Cetostearyl alcohol (6% w/w) Propyl parahydroxybenzoate (E216) (0.05% w/w) For the full list of excipients, see section 6.1 3. Pharmaceutical form Cream. The product is a white cream with a high percentage (about 70%) of fats and oils. 4. Clinical particulars 4.1 Therapeutic indications Locoid Lipocream is indicated in adults, children and infants. The product is recommended for clinical use in the treatment of conditions responsive to topical corticosteroids e.g. eczema, dermatitis and psoriasis. Topical corticosteroids are not generally indicated in psoriasis but may be acceptable in psoriasis excluding widespread plaque psoriasis provided warnings are given; see section 4.4 Special warnings and precautions for use. 4.2 Posology and method of administration Posology _Adults and older people_ The same dose is used for adults and older people, as clinical evidence would indicate that no special dosage regimen is necessary in the elderly. _Paediatric population_ Long term treatment should be avoided where possible. _Infants_ Therapy should be limited if possible to a maximum of seven days. Method of administration For cutaneous use. Dosage: To be applied evenly and sparingly no more than twice daily Application may be made under occlusion in the more resistant lesions such as thickened psoriatic plaques on elbows and knees. Due to the formulation of the base the product may be used both for dry scaly lesions and for moist or weeping lesions. 4.3 Contraindications Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. This preparation is contraindicated in the presence of untreated viral or fungal infections, tubercular or syphilitic lesions, peri-oral dermatitis, acne vulgaris and rosacea 完全なドキュメントを読む